Bill Snyder

September 29, 2022

Vanderbilt Translational Research Forum set for Oct. 21

Vanderbilt Translational Research Forum, an annual celebration of the “translation” of scientific discovery into clinical practice, will be held Oct. 21 at the Vanderbilt University Student Life Center.

By Bill Snyder
Kaydi Naylor, 4, touches an eastern chain kingsnake at last week’s “MEGAMicrobe Express” community science fair at the Warner Elementary Arts Magnet School in East Nashville.
September 22, 2022

MEGAMicrobe event shows children that science can be fun

More than 100 children who attended the “MEGAMicrobe Express” community science fair on Sept. 17 at the Warner Elementary Arts Magnet School in East Nashville.

By Bill Snyder
September 22, 2022

Self named co-principal investigator of Vanderbilt’s Clinical and Translational Science Award

Wesley Self, MD, MPH, a physician-scientist at Vanderbilt University Medical Center, has been named co-principal investigator (co-PI) of Vanderbilt’s Clinical and Translational Science Award (CTSA).  

By Bill Snyder
Medical laboratory scientist Gladys Garrison, MT, MS, loads reagents to prepare DNA samples for analysis in the VUMC Molecular Diagnostics Lab.
September 22, 2022

Nominations sought for Research Staff Awards

Nominations for the 2022 Vanderbilt University School of Medicine Research Staff Awards are now being accepted.

By Bill Snyder
September 13, 2022

VUMC leads effort to map heart disease-causing genetic variations

Researchers from Vanderbilt University Medical Center, Stanford Medicine, the University of Toronto and Brigham and Women’s Hospital in Boston have joined forces to “map” the specific variations in more than 25 key cardiac disease genes that negatively affect heart function.

By Bill Snyder
September 8, 2022

PheWAS reveals post-COVID-19 diagnoses

Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.

By Bill Snyder
September 7, 2022

VUMC study will evaluate alternative strategies for administering mpox vaccine

Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms.
By Bill Snyder
August 31, 2022

MEGAMicrobe event to explore world of microbes Sept. 17

By Bill Snyder
August 25, 2022

New high-tech biobank safeguards critical specimens

By Bill Snyder
August 25, 2022

Study describes how E. coli co-opts cells, causes recurrent UTIs

Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.
By Bill Snyder
August 25, 2022

Rheumatoid arthritis and heart disease: a common path

An increase in certain antibodies in patients with rheumatoid arthritis can serve as a predictive biomarker for cardiovascular disease, Vanderbilt researchers have discovered.
By Bill Snyder
August 24, 2022

COVID antibody research conducted at VUMC lands national award

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.
By Bill Snyder
1 … 19 20 21 22 23 … 115